The Senate Special Committee on Aging on Wednesday (Dec. 9) will hold the first in a series of hearings probing the reasons for recent large price increases for off-patent drugs. “The hearing will seek to provide insight into the causes of these sudden, aggressive price hikes on off-patent drugs and the effect these egregious price increases have on patients’ access to medication,” according to a joint release by Chair Susan Collins (R-ME) and ranking Democrat Claire McCaskill (MO). “The Committee...